Clinical Trials Logo

Clinical Trial Summary

To study the effect of rivaroxaban anticoagulant therapy for 12 weeks in patients with left ventricular mural thrombus by contrast echocardiography before and after treatment, so as to provide basis and foundation for further study and treatment selection in the future; To provide further relevant data for the treatment outcome, treatment duration and influencing factors of left ventricular mural thrombosis; It is of great sociological and health economic significance to find more effective and safe anticoagulant treatment strategies for patients with left ventricular mural thrombosis, which will reduce the incidence of embolism and bleeding.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04970381
Study type Interventional
Source China National Center for Cardiovascular Diseases
Contact Qing Qing, Master
Email www.sunnydog1028@163.com
Status Recruiting
Phase N/A
Start date July 22, 2021
Completion date December 30, 2023